Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma
- 2 October 2009
- journal article
- case report
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 97 (2) , 291-294
Abstract
Paraneoplastic cerebellar degeneration is a rare neurological disorder that frequently precedes the detection of malignancy. Here, we report the case of a 60 year-old woman with locally advanced squamous cell carcinoma of the tongue who developed a subacute cerebellar syndrome associated with the presence of anti-CV2/CRMP5 antibodies in the cerebrospinal fluid, after achieving complete remission of the primary tumor and the involved cervical lymph nodes by chemoradiation. The patient’s symptoms on presentation were dizziness and gait unsteadiness. On examination she showed dysarthria, nystagmus and limb and gait ataxia. The diagnosis of paraneoplastic cerebellar syndrome was made on the basis of the clinical findings and immunological testing that revealed the presence of anti-CV2/CRMP5 antibodies in the patient’s cerebrospinal fluid. This syndrome, which is very rare in association with head and neck cancer, commonly precedes the detection of malignancy by a year or more and has been documented in only a few cases after completion of anticancer treatment.Keywords
This publication has 19 references indexed in Scilit:
- Chorée paranéoplasique et troubles du comportement chez un patient présentant des anticorps anti-CV2/CRMP5 et deux cancers différentsRevue Neurologique, 2010
- Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodiesJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Ovarian cancer and late onset paraneoplastic cerebellar degenerationArchives of Gynecology and Obstetrics, 2008
- Paraneoplastic syndromes of the CNSThe Lancet Neurology, 2008
- Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin- and anti-CV2/CRMP5 associated paraneoplastic neurological syndromesEuropean Journal of Neurology, 2007
- Management of paraneoplastic neurological syndromes: report of an EFNS Task ForceEuropean Journal of Neurology, 2006
- Recommended diagnostic criteria for paraneoplastic neurological syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Paraneoplastic Syndromes Involving the Nervous SystemNew England Journal of Medicine, 2003
- Bazex SyndromeDermatology, 2001
- Paraneoplastic cerebellar degenerationJournal of Neuro-Oncology, 1984